Clinical Trials Logo

Clinical Trial Summary

Incidence and morbi-mortality of Pneumocystis pneumonia (PCP) are increasing. Early and fast diagnosis and treatment improve PCP prognosis. Biological diagnosis is based on the detection of Pneumocystis jirovecii, mainly by PCR, in broncho-alveolar lavage (BAL) obtained from bronchial fibroscopy. However this invasive exam is not always possible in emergency in suspected patient and others non invasive (sputa) and/or non-targeted (bronchial aspiration) are sent to the laboratory (25% of cases, data from the Grenoble University Hospital). Diagnosis performances of these non invasive/non-targeted samples are not clearly established. In this study, the investigators aimed to establish the diagnosis value of non-invasive and/or non-targeted respiratory samples (oral fluids, sputa and bronchial aspiration) for the PCP diagnosis, compared to the gold-standard (Pneumocystis PCR on BAL, beta-D-glucans testing on serum and radio-clinical records).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03613025
Study type Interventional
Source University Hospital, Grenoble
Contact
Status Completed
Phase N/A
Start date June 25, 2018
Completion date December 24, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04368559 - Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation Phase 3
Enrolling by invitation NCT03856229 - Short-term Steroid Therapy in Patients With P. Jirovecii Pneumonia Due to HIV / AIDS N/A
Not yet recruiting NCT04851015 - Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia Phase 3
Completed NCT00870857 - Prevalence and Pathogenesis of Lung Disease in a Large HIV Cohort-coordinating Center N/A
Recruiting NCT05707156 - Prospective Observational Study on the Incidence of Opportunistic Fungal Infections
Recruiting NCT02944045 - Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised Patients Phase 3